Polish investor Tar Heel Capital has reached a first and final close of its latest fund, THC 2, at 50 million euros ($64.5 million). Athos Partners acted as sole placement advisor to the Fund.
PRESS RELEASE
Tar Heel Capital (“Tar Heel” or “THC”) announces the first and final close of its latest fund, THC 2, at €50 million. THC initiated its maiden institutional fundraising and the Fund secured commitments from leading, well regarded European institutional investors within three months. Athos Partners acted as sole placement advisor to the Fund.
Grzegorz Bielowicki, Managing Partner and founder of Tar Heel Capital, said:
“Having successfully invested on a deal-by-deal basis for more than a decade, we decided to raise our first institutional fund. Investors have been wary of Central Europe due to the apparent lack of dealflow combined with the large amounts of capital raised between 2007 and 2010. We have been able to demonstrate that the small-cap segment in Poland remains attractive, competition is low and dealflow is not only abundant but of high quality. This is reinforced by the country’s fundamentals, which favour private equity investors looking for growing yet institutional markets. This allowed us to reach our target much faster than expected.”
About Tar Heel Capital Founded in 1998 Tar Heel Capital acquires majority stakes in Poland-based small and medium sized companies with strong business models and niche market positions. These companies usually have the potential to double or triple in size and bear significant value creation potential through improved operations, which is core to THC’s deep operational approach.
About Athos Partners Athos Partners is an independent placement advisory firm dedicated to assisting leading mid-
market private equity firms. Headquartered in Monaco, it offers highly differentiated fundraising solutions whilst ensuring a full alignment of interests with its clients.